Modern Healthcare News
 
RSS feed

Supply Chain news and information

News
Boston Scientific earnings socked by litigation, acquisition charges
By John N. Frank and Jaimy Lee | July 24, 2014 | Basic Web Basic Web Subscription Details
Boston Scientific Corp. reported second-quarter net income of only $4 million because of several charges related to acquisitions and divestitures, along with litigation and restructuring charges, but pointed to a 4% jump in revenue as a positive development for the medical-device maker. Without the...
FULL STORY »
 

Information
GSK asks European regulator to OK malaria vaccine despite low efficacy in children
By Associated Press | July 24, 2014
Pharma giant GSK said Thursday it is submitting its malaria vaccine for regulatory approval to the European Medicines Agency.
FULL STORY »
 

Information
FDA spars with recalcitrant compounding pharmacy, again
By Wall Street Journal | July 23, 2014
For the third time in 15 months, the FDA is warning healthcare providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the...
FULL STORY »
 

News
Sales of da Vinci robotic surgery systems continue to flag
By Jaimy Lee | July 22, 2014 | Basic Web Basic Web Subscription Details
Intuitive Surgical saw its revenue and income fall again in the second quarter as sales of its da Vinci robotic surgery systems continued to drop.
FULL STORY »
 

News
HHS reissues disputed 340B policy on orphan-drug discounts
By Jaimy Lee | July 21, 2014 | Basic Web Basic Web Subscription Details
HHS issued an interpretive rule that requires drug companies to provide discounts on orphan drugs sold through a federal program just months after a judge struck down the government's previous version of the rule.
FULL STORY »
 


Advertisement | View Media Kit

News
Thermo Fisher sells lab equipment company for $480 million
By Bob Herman | July 21, 2014 | Basic Web Basic Web Subscription Details
Thermo Fisher Scientific has agreed to sell Cole-Parmer Instrument Co. to private-equity firm GTCR for $480 million.
FULL STORY »
 

Magazine
Tax reform fears driving Big Pharma mergers
By Beth Kutscher | July 19, 2014 | Print Magazine Print Magazine Subscription Details
The rumblings that corporate tax reform will close favorable loopholes for pharmaceutical and biotechnology companies are getting louder, fueling a rush of high-dollar cross-border deals.
FULL STORY »
 

News
Dignity Health to pay feds $1.55 million for lost opioids
By Bob Herman | July 18, 2014 | Basic Web Basic Web Subscription Details
Dignity Health, San Francisco, agreed Wednesday to pay $1.55 million to resolve claims it mishandled controlled substances.
FULL STORY »
 

Information
AbbVie, Shire agree on $55B combination
By Associated Press | July 18, 2014
The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.
FULL STORY »
 

News
Stryker reports sales growth despite pricing pressure from hospitals
By Jaimy Lee | July 17, 2014 | Basic Web Basic Web Subscription Details
Stryker, a medical device manufacturer based in Kalamazoo, Mich., reported that U.S. sales rose 7.6% in the second quarter of 2014, but earnings growth was dampened by costs associated with acquisitions, research and product recalls.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.